Edited GluR2, a gatekeeper for motor neurone survival?

BioEssays

Volumn 30, Issue 11-12, 2008, Pages 1185-1192

  Buckingham, S D ^a   Kwak, S ^b   Jones, A K ^a   Blackshaw, S E ^a   Sattelle, David B ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMPA RECEPTOR; CALCIUM ION; GLUTAMATE RECEPTOR 2; IONOTROPIC RECEPTOR; RECEPTOR SUBUNIT; RNA; CALCIUM; GLUTAMATE RECEPTOR IONOTROPIC, AMPA 2; ION; UNCLASSIFIED DRUG;

AMYOTROPHIC LATERAL SCLEROSIS; CALCIUM TRANSPORT; CELL MEMBRANE PERMEABILITY; CELL SURVIVAL; DEGENERATIVE DISEASE; EXCITOTOXICITY; HUMAN; MOLECULAR GENETICS; MOTONEURON; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; PHENOTYPE; REVIEW; RNA EDITING; ANIMAL; BIOLOGICAL MODEL; GENETIC TRANSCRIPTION; METABOLISM; NERVE CELL; PERMEABILITY; PHYSIOLOGY; PROTEIN SYNTHESIS;

PYRONIA TITHONUS;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; CALCIUM; HUMANS; IONS; MODELS, BIOLOGICAL; MOTOR NEURONS; NEURONS; PERMEABILITY; PROTEIN BIOSYNTHESIS; RECEPTORS, AMPA; RNA EDITING; TRANSCRIPTION, GENETIC;

EID: 58149165222     PISSN: 02659247     EISSN: None     Source Type: Journal    
DOI: 10.1002/bies.20836     Document Type: Review

References (73)

1. Kwak S, Weiss JH. 2006. Calcium-permeable AMPA channels in neurodegenerative disease and ischemia. Curr Opin Neurobiol 16: 281-287.
2. Mayer ML. 2005. Glutamate receptor ion channels. Curr Opin Neurobiol 15:282-288.
3. Zukin RS, Bennett MV. 1995. Alternatively spliced isoforms of the NMDARI receptor subunit. Trends Neurosci 18:306-313.
4. Sommer B, Keinanen K, Verdoorn TA, Wisden W, Burnashev N, et al. 1990. Flip and flop: a cell-specific functional switch in glutamate-operated channels of the CNS. Science 249:1580-1585.
5. Coussen F, Perrais D, Jaskolski F, Sachidhanandam S, Normand E, et al. 2005. Co-assembly of two GluR6 kainate receptor splice variants within a functional protein complex. Neuron 47:555-566.
6. Jaskolski F, Normand E, Mulle C, Coussen F. 2005. Differential trafficking of GluR7 kainate receptor subunit splice variants. J Biol Chem 280: 22968-22976.
7. Seeburg PH. 2002. A-to-I editing: new and old sites, functions and speculations. Neuron 35:17-20.
8. Mehler MF, Mattick JS. 2007. Noncoding RNAs and RNA editing in brain development, functional diversification, and neurological disease. Physiol Rev 87:799-823.
9. Simpson L, Emeson RB. 1996. RNA editing. Annu Rev Neurosci 19: 27-52.
10. Barbon A, Vallini I, La Via L, Marchina E, Barlati S. 2003. Glutamate receptor RNA editing: a molecular analysis of GluR2, GluR5 and GluR6 in human brain tissues and in NT2 cells following in vitro neural differentiation. Brain Res Mol Brain Res 117:168-178.
11. Grauso M, Reenan RA, Culetto E, Sattelle DB. 2002. Novel putative nicotinic acetylcholine receptor subunit genes, Dalpha5, Dalpha6 and Dalpha7, in Drosophila melanogaster identify a new and highly conserved target of adenosine deaminase acting on RNA-mediated A-to-I pre-mRNA editing. Genetics 160:1519-1533.
12. Hoopengardner B, Bhalla T, Staber C, Reenan R. 2003. Nervous system targets of RNA editing identified by comparative genomics. Science 301:832-836.
13. Es-Salah Z, Lapied B, Le Goff G, Hamon A. 2008. RNA editing regulates insect gamma-aminobutyric acid receptor function and insecticide sensitivity. Neuroreport 19:939-943.
14. Semenov EP, Pak WL. 1999. Diversification of Drosophila chloride channel gene by multiple posttranscriptional mRNA modifications. Journal of Neurochemistry 72:66-72.
15. Sattelle DB, Jones AK, Sattelle BM, Matsuda K, Reenan R, Biggin PC. 2005. Edit, cut and paste in the nicotinic acetylcholine receptor gene family of Drosophila melanogaster. Bioessays 27:366-376.
16. Jones AK, Brown LA, Sattelle DB. 2007. Insect nicotinic acetylcholine receptor gene families: from genetic model organism to vector, pest and beneficial species. Invert Neurosci 7:67-73.
17. Meier JC, Henneberger C, Melnick I, Racca C, Harvey RJ, et al. 2005. RNA editing produces glycine receptor [α]3P185L, resulting in high agonist potency. Nat Neurosci 8:736-744.
18. Rula EY, Lagrange AH, Jacobs MM, Hu N, Macdonald RL, Emeson RB. 2008. Developmental Modulation of GABAA Receptor Function by RNA Editing. J Neurosci 28:6196-6201.
19. Gurevich I, Tamir H, Arango V, Dwork AJ, Mann JJ, Schmauss C. 2002. Altered editing of serotonin 2C receptor pre-mRNA in the prefrontal cortex of depressed suicide victims. Neuron 34:349-356.
20. Sommer B, Kohler M, Sprengel R, Seeburg PH. 1991. RNA editing in brain controls a determinant of ion flow in glutamate-gated channels. Cell 67:11-19.
21. Nitatori T, Sato N, Waguri S, Karasawa Y, Araki H, et al. 1995. Delayed neuronal death in the CA1 pyramidal cell layer of the gerbil hippocampus following transient ischemia is apoptosis. J Neurosci 15:1001-1011.
22. Kirino T. 1982. Delayed neuronal death in the gerbil hippocampus following ischemia. Brain Res 239:57-69.
23. Choi DW. 1995. Calcium: Still center-stage in hypoxic-ischemic neuronal death. Trends in Neurosciences 18:58-60.
24. Tanaka H, Grooms SY, Bennett MV, Zukin RS. 2000. The AMPAR subunit Glu. R2:still front and center-stage. Brain Res 886:190-207.
25. Oguro K, Oguro N, Kojima T, Grooms SY, Calderone A, et al. 1999. Knockdown of AMPA receptor GluR2 expression causes delayed neurodegeneration and increases damage by sublethal ischemia in hippocampal CA1 and CA3 neurons. J Neurosci 19: 9218-9227.
26. 2+-permeable AMPA receptor promotes delayed cell death of hippocampal CA1 neurons following transient forebrain ischemia. Neurosci Res 46:41-51.
27. Aronoff R, Mellem JE, Maricq AV, Sprengel R, Seeburg PH. 2004. Neuronal toxicity in Caenorhabditis elegans from an editing site mutant in glutamate receptor channels. J Neurosci 24:8135-8140.
28. Brusa R, Zimmermann F, Koh DS, Feldmeyer D, Gass P, et al. 1995. Early-onset epilepsy and postnatal lethality associated with an editing-deficient GluR-B allele in mice. Science 270:1677-1680.
29. Jia Z, Agopyan N, Miu P, Xiong Z, Henderson J, et al. 1996. Enhanced LTP in mice deficient in the AMPA receptor GluR2. Neuron 17:945-956.
30. Peng PL, Zhong X, Tu W, Soundarapandian MM, Molner P, et al. 2006. ADAR2-dependent RNA editing of AMPA receptor subunit GluR2 determines vulnerability of neurons in forebrain ischemia. Neuron 49: 719-733.
31. Vandenberghe W, Robberecht W, Brorson JR. 2000. AMPA receptor calcium permeability, GluR2 expression, and selective motoneuron vulnerability. J Neurosci 20:123-132.
32. Shaw PJ, Williams TL, Slade JY, Eggett CJ, Ince PG. 1999. Low expression of GluR2 AMPA receptor subunit protein by human motor neurons. NeuroReport 10:261-265.
33. Williams TL, Day NC, Ince PG, Kamboj RK, Shaw PJ. 1997. Calcium-permeable α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors: A molecular determinant of selective vulnerability in amyotrophic lateral sclerosis. Annals Neurol 42:200-207.
34. Sun H, Kawahara Y, Ito K, Kanazawa I, Kwak S. 2005. Expression profile of AMPA receptor subunit mRNA in single adult rat brain and spinal cord neurons in situ. Neurosci Res 52:228-234.
35. Kawahara Y, Kwak S, Sun H, Ito K, Hashida H, et al. 2003. Human spinal motoneurons express low relative abundance of GluR2 mRNA: an implication for excitotoxicity in ALS. J Neurochem 85:680-689.
36. Vandenberghe W, Ihle EC, Patneau DK, Robberecht W, Brorson JR. 2000. AMPA Receptor Current Density, Not Desensitization, Predicts Selective Motoneuron Vulnerability. J Neurosci 20:7158-7166.
37. 2+-permeable AMPA receptors and selective vulnerability of motor neurons. J Neurol Sci 2000. 180:29-34.
38. Greig A, Donevan SD, Mujtaba TJ, Parks TN, Rao MS. 2000. Characterization of the AMPA-activated receptors present on motoneurons. J Neurochem 74:179-191.
39. Vandenberghe W, Bindokas VP, Miller RJ, Robberecht W, Brorson JR. 2001. Subcellular localization of calcium-permeable AMPA receptors in spinal motoneurons. European Journal of Neuroscience 14:305-314.
40. Sun H, Kawahara Y, Ito K, Kanazawa I, Kwak S. 2006. Slow and selective death of spinal motor neurons in vivo by intrathecal infusion of kainic acid: implications for AMPA receptor-mediated excitotoxicity in ALS. J Neurochem 98:782-791.
41. Tortarolo M, Grignaschi G, Calvaresi N, Zennaro E, Spaltro G, et al. 2006. Glutamate AMPA receptors change in motor neurons of SOD1G93A transgenic mice and their inhibition by a noncompetitive antagonist ameliorates the progression of amytrophic lateral sclerosis-like disease. J Neurosci Res 83:134-146.
42. Rembach A, Turner BJ, Bruce S, Cheah IK, Scott RL, et al. 2004. Antisense peptide nucleic acid targeting GluR3 delays disease onset and progression in the SOD1 G93A mouse model of familial ALS. J Neurosci Res 77:573-582.
43. Tateno M, Sadakata H, Tanaka M, Itohara S, Shin RM, et al. 2004. Calcium-permeable AMPA receptors promote misfolding of mutant SOD1 protein and development of amyotrophic lateral sclerosis in a transgenic mouse model. Hum Mol Genet 13:2183-2196.
44. Greger IH, Khatri L, Ziff EB. 2002. RNA editing at arg607 controls AMPA receptor exit from the endoplasmic reticulum. Neuron 34:759-772.
45. 2+-permeability. Mol Cell Neurosci 35:470-481.
46. Shaw PJ, Ince PG. 1997. Glutamate, excitotoxicity and amyotrophic lateral sclerosis. J Neurol 244:S3-14.
47. Takanori Ikenaga GHTEF. 2006. Co-occurrence of calcium-binding proteins and calcium-permeable glutamate receptors in the primary gustatory nucleus of goldfish. J Comp Neurol 499:90-105.
48. Alexianu ME, Ho BK, Mohamed AH, La Bella V, Smith RG, Appel SH. 1994. The role of calcium-binding proteins in selective motoneuron vulnerability in amyotrophic lateral sclerosis. Annals of Neurology 36: 846-858.
49. Sasaki S, Warita H, Komori T, Murakami T, Abe K, Iwata M. 2006. Parvalbumin and calbindin D-28k immunoreactivity in transgenic mice with a G93A mutant SOD1 gene. Brain Res 1083:196-203.
50. Takuma H, Kwak S, Yoshizawa T, Kanazawa I. 1999. Reduction of GluR2 RNA editing, a molecular change that increases calcium influx through AMPA receptors, selective in the spinal ventral gray of patients with amyotrophic lateral sclerosis. Ann Neurol 46:806-815.
51. Kawahara Y, Ito K, Sun H, Ito M, Kanazawa I, Kwak S. 2004. Regulation of glutamate receptor RNA editing and ADAR mRNA expression in developing human normal and Down's syndrome brains. Developmental Brain Research 148:151-155.
52. Kawahara Y, Ito K, Sun H, Aizawa H, Kanazawa I, Kwak S. 2004. Glutamate receptors: RNA editing and death of motor neurons. Nature 427:801.
53. Kawahara Y, Sun H, Ito K, Hideyama T, Aoki M, et al. 2006. Underediting of GluR2 mRNA, a neuronal death inducing molecular change in sporadic ALS, does not occur in motor neurons in ALS1 or SBMA. Neurosci Res 54:11-14.
54. Kwak S, Kawahara Y. 2005. Deficient RNA editing of GluR2 and neuronal death in amyotropic lateral sclerosis. J Mol Med 83:110-120.
55. Kuner R, Groom AJ, Bresink I, Kornau HC, Stefovska V, et al. 2005. Lateonset motoneuron disease caused by a functionally modified AMPA receptor subunit. Proc Natl Acad Sci USA 102:5826-5831.
56. Seeburg PH, Single F, Kuner T, Higuchi M, Sprengel R. 2001. Genetic manipulation of key determinants of ion flow in glutamate receptor channels in the mouse. Brain Res 907:233-243.
57. 2+ permeability. J Neurosci 21:4572-4581.
58. Xianglian Ni GJSMM-C. 2007. Developmental characteristics of AMPA receptors in chick lumbar motoneurons. Developmental Neurobiology 67:1419-1432.
59. Palladino MJ, Keegan LP, O'Connell MA, Reenan RA. 2000. dADAR, a Drosophila double-stranded RNA-specific adenosine deaminase is highly developmentally regulated and is itself a target for RNA editing. RNA 6:1004-1018.
60. Pawlak V, Schupp BJ, Single FN, Seeburg PH, Kohr G. 2005. Impaired synaptic scaling in mouse hippocampal neurones expressing NMDA receptors with reduced calcium permeability. J Physiol 562:771-783.
61. Iihara K, Joo DT, Henderson J, Sattler R, Taverna FA, et al. 2001. The influence of glutamate receptor 2 expression on excitotoxicity in Glur2 null mutant mice. J Neurosci 21:2224-2239.
62. Piccini A, Malinow R. 2002. Critical postsynaptic density 95/disc large/ zonula occludens-1 interactions by glutamate receptor 1 (GluR1) and GluR2 required at different subcellular sites. J Neurosci 22:5387-5392.
63. Rothstein JD, Martin LJ, Kuncl RW. 1992. Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis. N Engl J Med 326:1464-1468.
64. Boillee S, Vande Velde C, Cleveland DW. 2006. ALS: a disease of motor neurons and their nonneuronal neighbors. Neuron 52:39-59.
65. Van Damme P, Bogaert E, Dewil M, Hersmus N, Kiraly D, et al. 2007. Astrocytes regulate GluR2 expression in motor neurons and their vulnerability to excitotoxicity. Proc Natl Acad Sci USA 104:14825-14830.
66. Kawahara Y, Ito K, Sun H, Kanazawa I, Kwak S. 2003. Low editing efficiency of GluR2 mRNA is associated with a low relative abundance of ADAR2 mRNA in white matter of normal human brain. Eur J Neurosci 18:23-33.
67. Iino M, Goto K, Kakegawa W, Okado H, Sudo M, et al. 2001. Gliasynapse interaction through Ca2+-permeable AMPA receptors in Bergmann glia. Science 292:926-929.
68. Cenci C, Barzotti R, Galeano F, Corbelli S, Rota R, et al. 2008. Down-regulation of RNA editing in Pediatric Astrocytomas: ADAR2 editing activity inhibits cell migration and proliferation. J Biol Chem 283:7251-7260.
69. Maas S, Patt S, Schrey M, Rich A. 2001. Underediting of glutamate receptor GluR-B mRNA in malignant gliomas. Proc Natl Acad Sci USA 98:14687-14692.
70. Lomeli H, Mosbacher J, Melcher T, Hoger T, Geiger JR, et al. 1994. Control of kinetic properties of AMPA receptor channels by nuclear RNA editing. Science 266:1709-1713.
71. Wang Q, Khillan J, Gadue P, Nishikura K. 2000. Requirement of the RNA editing deaminase ADAR1 gene for embryonic erythropoiesis. Science 290:1765-1768.
72. Higuchi M, Maas S, Single FN, Hartner J, Rozov A, et al. 2000. Point mutation in an AMPA receptor gene rescues lethality in mice deficient in the RNA-editing enzyme ADAR2. Nature 406:78-81.
73. Nishimoto Y, Yamashita T, Hideyama T, Tsuji S, Suzuki N, Kwak S. 2008. Determination of editors at the novel A-to-I editing positions. Neurosci Res 61:201-206.